• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对肺炎链球菌8型的小鼠单克隆抗体的基因使用情况及效能表征

Characterization of gene use and efficacy of mouse monoclonal antibodies to Streptococcus pneumoniae serotype 8.

作者信息

Yano Masahide, Pirofski Liise-anne

机构信息

Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.

出版信息

Clin Vaccine Immunol. 2011 Jan;18(1):59-66. doi: 10.1128/CVI.00368-10. Epub 2010 Nov 10.

DOI:10.1128/CVI.00368-10
PMID:21068211
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3019784/
Abstract

Streptococcus pneumoniae is the most common cause of community-acquired pneumonia in the United States and globally. Despite the availability of pneumococcal capsular polysaccharide (PPS) and protein conjugate-based vaccines, the prevalence of antibiotic-resistant pneumococcal strains, serotype (ST) replacement in nonconjugate vaccine strains, and uncertainty as to whether the PPS vaccine that is used in adults protects against pneumonia emphasize the need for continued efforts to understand the nature of protective PPS antibody responses. In this study, we generated mouse monoclonal antibodies (MAbs) to a conjugate consisting of the PPS of serotype 8 (PPS8) S. pneumoniae and tetanus toxoid. Thirteen MAbs, including four IgMs that bound to PPS8 and phosphorylcholine (PC) and five IgMs and four IgG1s that bound to PPS8 but not PC, were produced, and their nucleotide sequences, epitope and fine specificity, and efficacy against lethal challenge with ST8 S. pneumoniae were determined. MAbs that bound to PPS8 exhibited gene use that was distinct from that exhibited by MAbs that bound to PC. Only PPS8-binding MAbs that did not bind PC were protective in mice. All 13 MAbs used germ line variable-region heavy (V(H)) and light (V(L)) chain genes, with no evidence of somatic hypermutation. Our data reveal a relationship between PPS specificity and V(H) gene use and MAb efficacy in mice. These findings provide insight into the relationship between antibody molecular structure and function and hold promise for the development of novel surrogates for pneumococcal vaccine efficacy.

摘要

肺炎链球菌是美国及全球社区获得性肺炎最常见的病因。尽管有肺炎球菌荚膜多糖(PPS)和基于蛋白质结合物的疫苗,但耐抗生素肺炎球菌菌株的流行、非结合疫苗菌株中的血清型(ST)替换,以及成人使用的PPS疫苗是否能预防肺炎的不确定性,都凸显了持续努力了解保护性PPS抗体反应本质的必要性。在本研究中,我们制备了针对由8型肺炎链球菌(S. pneumoniae)的PPS(PPS8)与破伤风类毒素组成的结合物的小鼠单克隆抗体(MAb)。产生了13种MAb,包括4种与PPS8和磷酸胆碱(PC)结合的IgM、5种与PPS8但不与PC结合的IgM和4种IgG1,并确定了它们的核苷酸序列、表位和精细特异性,以及对8型肺炎链球菌致死性攻击的效力。与PPS8结合的MAb表现出与与PC结合的MAb不同的基因使用情况。只有不与PC结合的与PPS8结合的MAb在小鼠中具有保护作用。所有13种MAb都使用种系可变区重链(V(H))和轻链(V(L))基因,没有体细胞超突变的证据。我们的数据揭示了PPS特异性与V(H)基因使用以及小鼠中MAb效力之间的关系。这些发现为抗体分子结构与功能之间的关系提供了见解,并为开发肺炎球菌疫苗效力的新型替代指标带来了希望。

相似文献

1
Characterization of gene use and efficacy of mouse monoclonal antibodies to Streptococcus pneumoniae serotype 8.针对肺炎链球菌8型的小鼠单克隆抗体的基因使用情况及效能表征
Clin Vaccine Immunol. 2011 Jan;18(1):59-66. doi: 10.1128/CVI.00368-10. Epub 2010 Nov 10.
2
Isolation and Characterization of Human Monoclonal Antibodies to Pneumococcal Capsular Polysaccharide 3.肺炎球菌荚膜多糖 3 型人源单克隆抗体的分离与鉴定
Microbiol Spectr. 2021 Dec 22;9(3):e0144621. doi: 10.1128/Spectrum.01446-21. Epub 2021 Nov 10.
3
Structure-function relationships for human antibodies to pneumococcal capsular polysaccharide from transgenic mice with human immunoglobulin Loci.具有人免疫球蛋白基因座的转基因小鼠产生的抗肺炎球菌荚膜多糖人抗体的结构-功能关系。
Infect Immun. 2002 Sep;70(9):4977-86. doi: 10.1128/IAI.70.9.4977-4986.2002.
4
Production of protective human antipneumococcal antibodies by transgenic mice with human immunoglobulin loci.用人免疫球蛋白基因座的转基因小鼠生产保护性人抗肺炎球菌抗体。
Infect Immun. 2000 Apr;68(4):1820-6. doi: 10.1128/IAI.68.4.1820-1826.2000.
5
Efficacy of opsonic and nonopsonic serotype 3 pneumococcal capsular polysaccharide-specific monoclonal antibodies against intranasal challenge with Streptococcus pneumoniae in mice.调理素型和非调理素型3型肺炎球菌荚膜多糖特异性单克隆抗体对小鼠鼻内感染肺炎链球菌的疗效。
Infect Immun. 2009 Apr;77(4):1502-13. doi: 10.1128/IAI.01075-08. Epub 2009 Jan 21.
6
Immunogenetic analysis of the immune response to pneumococcal polysaccharide.对肺炎球菌多糖免疫反应的免疫遗传学分析。
Eur J Immunol. 2000 Apr;30(4):1214-23. doi: 10.1002/(SICI)1521-4141(200004)30:4<1214::AID-IMMU1214>3.0.CO;2-D.
7
Pneumococcal capsular polysaccharide vaccine-mediated protection against serotype 3 Streptococcus pneumoniae in immunodeficient mice.肺炎球菌荚膜多糖疫苗介导的对免疫缺陷小鼠中3型肺炎链球菌的保护作用。
Infect Immun. 2007 Apr;75(4):1643-50. doi: 10.1128/IAI.01371-06. Epub 2007 Jan 12.
8
Reduction of Streptococcus pneumoniae Colonization and Dissemination by a Nonopsonic Capsular Polysaccharide Antibody.非调理素性荚膜多糖抗体对肺炎链球菌定植与播散的抑制作用
mBio. 2016 Feb 2;7(1):e02260-15. doi: 10.1128/mBio.02260-15.
9
Human monoclonal antibodies isolated from a primary pneumococcal conjugate Vaccinee demonstrates the expansion of an antigen-driven Hypermutated memory B cell response.从原发性肺炎球菌结合疫苗接种者中分离出的人源单克隆抗体表明,抗原驱动的超突变记忆 B 细胞反应得到了扩展。
BMC Infect Dis. 2018 Dec 4;18(1):613. doi: 10.1186/s12879-018-3517-7.
10
Somatic hypermutation and diverse immunoglobulin gene usage in the human antibody response to the capsular polysaccharide of Streptococcus pneumoniae Type 6B.人对6B型肺炎链球菌荚膜多糖抗体应答中的体细胞超突变及多样的免疫球蛋白基因利用
Infect Immun. 2004 Jun;72(6):3505-14. doi: 10.1128/IAI.72.6.3505-3514.2004.

引用本文的文献

1
Antigen-driven Convergent Evolution of Polysaccharide-specific "DH-less" B Cells in Glycoconjugate Immunized Mice.抗原驱动的糖缀合物免疫小鼠中多糖特异性“DH 缺失”B 细胞的趋同进化。
Immunohorizons. 2024 Aug 1;8(8):511-526. doi: 10.4049/immunohorizons.2400055.
2
Promoting Fc-Fc interactions between anti-capsular antibodies provides strong immune protection against .促进抗荚膜抗体之间的 Fc-Fc 相互作用可提供针对 的强大免疫保护。
Elife. 2023 Mar 22;12:e80669. doi: 10.7554/eLife.80669.
3
The Immunoglobulin M Response to Pneumococcal Polysaccharide Vaccine Is Sufficient for Conferring Immunity.免疫球蛋白 M 对肺炎球菌多糖疫苗的反应足以提供免疫力。
J Infect Dis. 2022 Nov 11;226(10):1852-1856. doi: 10.1093/infdis/jiac339.
4
A Structural Model for the Ligand Binding of Pneumococcal Serotype 3 Capsular Polysaccharide-Specific Protective Antibodies.肺炎链球菌 3 型荚膜多糖特异性保护性抗体的配体结合结构模型。
mBio. 2021 Jun 29;12(3):e0080021. doi: 10.1128/mBio.00800-21. Epub 2021 Jun 1.
5
Recent Advances in the Synthesis of Glycoconjugates for Vaccine Development.糖缀合物用于疫苗开发的最新进展。
Molecules. 2018 Jul 13;23(7):1712. doi: 10.3390/molecules23071712.
6
A Capsular Polysaccharide-Specific Antibody Alters Streptococcus pneumoniae Gene Expression during Nasopharyngeal Colonization of Mice.荚膜多糖特异性抗体在肺炎链球菌鼻咽定植期间改变其基因表达。
Infect Immun. 2018 Jun 21;86(7). doi: 10.1128/IAI.00300-18. Print 2018 Jul.
7
A semisynthetic serotype 8 glycoconjugate vaccine.一种半合成8型糖共轭疫苗。
Sci Transl Med. 2017 Mar 8;9(380). doi: 10.1126/scitranslmed.aaf5347.
8
Reduction of Streptococcus pneumoniae Colonization and Dissemination by a Nonopsonic Capsular Polysaccharide Antibody.非调理素性荚膜多糖抗体对肺炎链球菌定植与播散的抑制作用
mBio. 2016 Feb 2;7(1):e02260-15. doi: 10.1128/mBio.02260-15.
9
A serotype 3 pneumococcal capsular polysaccharide-specific monoclonal antibody requires Fcγ receptor III and macrophages to mediate protection against pneumococcal pneumonia in mice.一种血清型 3 肺炎球菌荚膜多糖特异性单克隆抗体需要 Fcγ 受体 III 和巨噬细胞来介导对肺炎球菌肺炎的保护作用。
Infect Immun. 2012 Apr;80(4):1314-22. doi: 10.1128/IAI.06081-11. Epub 2012 Jan 30.
10
Antibodies to Streptococcus pneumoniae capsular polysaccharide enhance pneumococcal quorum sensing.抗肺炎链球菌荚膜多糖抗体增强肺炎链球菌群体感应。
mBio. 2011 Nov 1;2(5). doi: 10.1128/mBio.00176-11. Print 2011.

本文引用的文献

1
The efficacy of pneumococcal capsular polysaccharide-specific antibodies to serotype 3 Streptococcus pneumoniae requires macrophages.肺炎球菌荚膜多糖特异性抗体对 3 型肺炎链球菌的功效需要巨噬细胞。
Vaccine. 2010 Nov 3;28(47):7542-50. doi: 10.1016/j.vaccine.2010.08.061. Epub 2010 Aug 26.
2
Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates.5岁以下儿童肺炎链球菌所致疾病负担:全球估计数
Lancet. 2009 Sep 12;374(9693):893-902. doi: 10.1016/S0140-6736(09)61204-6.
3
The contribution of naturally occurring IgM antibodies, IgM cross-reactivity and complement dependency in murine humoral responses to pneumococcal capsular polysaccharides.天然存在的IgM抗体、IgM交叉反应性及补体依赖性在小鼠对肺炎球菌荚膜多糖体液反应中的作用。
Vaccine. 2009 Sep 25;27(42):5806-15. doi: 10.1016/j.vaccine.2009.07.063. Epub 2009 Aug 4.
4
Low levels of IgM antibodies against phosphorylcholine-A increase mortality risk in patients undergoing haemodialysis.针对磷酸胆碱-A 的 IgM 抗体水平较低会增加血液透析患者的死亡风险。
Nephrol Dial Transplant. 2009 Nov;24(11):3454-60. doi: 10.1093/ndt/gfp309. Epub 2009 Jun 23.
5
Serotype replacement in perspective.血清型替代的前景。
Vaccine. 2009 Aug 21;27 Suppl 3:C22-4. doi: 10.1016/j.vaccine.2009.06.004. Epub 2009 Jun 21.
6
Low levels of IgM antibodies against phosphorylcholine predict development of acute myocardial infarction in a population-based cohort from northern Sweden.瑞典北部一项基于人群的队列研究中,抗磷酸胆碱IgM抗体水平低预示急性心肌梗死的发生。
Eur J Cardiovasc Prev Rehabil. 2009 Jun;16(3):382-6. doi: 10.1097/HJR.0b013e32832a05df.
7
Efficacy of opsonic and nonopsonic serotype 3 pneumococcal capsular polysaccharide-specific monoclonal antibodies against intranasal challenge with Streptococcus pneumoniae in mice.调理素型和非调理素型3型肺炎球菌荚膜多糖特异性单克隆抗体对小鼠鼻内感染肺炎链球菌的疗效。
Infect Immun. 2009 Apr;77(4):1502-13. doi: 10.1128/IAI.01075-08. Epub 2009 Jan 21.
8
Progress in introduction of pneumococcal conjugate vaccine--worldwide, 2000-2008.2000 - 2008年全球肺炎球菌结合疫苗引入情况的进展
MMWR Morb Mortal Wkly Rep. 2008 Oct 24;57(42):1148-51.
9
Invasive pneumococcal disease: epidemiology in children and adults prior to implementation of the conjugate vaccine in the Oxfordshire region, England.侵袭性肺炎球菌疾病:在英国牛津郡地区实施结合疫苗之前儿童和成人的流行病学情况。
J Med Microbiol. 2008 Apr;57(Pt 4):480-487. doi: 10.1099/jmm.0.47690-0.
10
Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States.美国疫苗可预防疾病的发病率和死亡率的历史比较。
JAMA. 2007 Nov 14;298(18):2155-63. doi: 10.1001/jama.298.18.2155.